Antiemesis Clinical Practice Guidelines in Oncology

被引:48
作者
Ettinger, David S. [1 ]
Armstrong, Debra K. [2 ]
Barbour, Sally [3 ]
Berger, Michael J. [4 ]
Bierman, Philip J. [5 ]
Bradbury, Bob
Ellis, Georgianna [6 ]
Kirkegaard, Steve [7 ]
Kloth, Dwight D. [8 ]
Kris, Mark G. [9 ]
Lim, Dean [10 ]
Michaud, Laura Boehnke [11 ]
Nabati, Lida [12 ]
Noonan, Kim [12 ]
Rugo, Hope S. [13 ]
Siler, Darby [14 ]
Sorscher, Steven M. [15 ,16 ]
Stelts, Sundae [17 ]
Stucky-Marshall, Lisa [18 ]
Todaro, Barbara [19 ]
Urba, Susan G. [20 ]
机构
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Sidney, BC, Canada
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Duke Canc Inst, Durham, England
[4] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA
[5] Nebraska Med Ctr, UNMC Eppley Canc Ctr, Omaha, NE USA
[6] Fred Hutchinson Canc Res Ctr Seattle Canc Care Al, Seattle, WA USA
[7] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[8] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[9] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[10] City Hope Comprehens Canc Ctr, Duarte, CA USA
[11] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[12] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[13] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[14] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL USA
[15] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA
[16] Washington Univ, Sch Med, St Louis, MO 63130 USA
[17] Univ Tennessee, Inst Canc, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA
[18] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA
[19] Roswell Pk Canc Inst, Buffalo, NY USA
[20] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2012年 / 10卷 / 04期
关键词
NCCN Clinical Practice Guidelines; NCCN Guidelines; antiemesis; nausea and vomiting; chemotherapy-induced; 5-HT3-receptor antagonists; NK-1 receptor antagonists; CHEMOTHERAPY-INDUCED NAUSEA; MODERATELY-EMETOGENIC CHEMOTHERAPY; HIGH-DOSE CISPLATIN; METOCLOPRAMIDE PLUS DEXAMETHASONE; RANDOMIZED CONTROLLED-TRIAL; MULTIPLE-DAY CHEMOTHERAPY; 5-HYDROXYTRYPTAMINE-3 RECEPTOR ANTAGONIST; ACUPUNCTURE-POINT STIMULATION; RECEIVING CANCER-CHEMOTHERAPY; PLACEBO-CONTROLLED TRIAL;
D O I
10.6004/jnccn.2012.0047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:456 / 485
页数:30
相关论文
共 157 条
[1]   METHODOLOGICAL ISSUES IN ANTIEMETIC STUDIES [J].
AAPRO, M .
INVESTIGATIONAL NEW DRUGS, 1993, 11 (04) :243-253
[2]   Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy [J].
Aapro, M. ;
Fabi, A. ;
Nole, F. ;
Medici, M. ;
Steger, G. ;
Bachmann, C. ;
Roncoroni, S. ;
Roila, F. .
ANNALS OF ONCOLOGY, 2010, 21 (05) :1083-1088
[3]   A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy [J].
Aapro, M. S. ;
Grunberg, S. M. ;
Manikhas, G. M. ;
Olivares, G. ;
Suarez, T. ;
Tjulandin, S. A. ;
Bertoli, L. F. ;
Yunus, F. ;
Morrica, B. ;
Lordick, F. ;
Macciocchi, A. .
ANNALS OF ONCOLOGY, 2006, 17 (09) :1441-1449
[4]  
Aapro Matti S, 2007, Ther Clin Risk Manag, V3, P1009
[5]   Anticipatory nausea and vomiting [J].
Aapro, MS ;
Molassiotis, A ;
Olver, I .
SUPPORTIVE CARE IN CANCER, 2005, 13 (02) :117-121
[6]  
AAPRO MS, 1981, CANCER CHEMOTH PHARM, V7, P11
[7]   DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].
AAPRO, MS ;
PLEZIA, PM ;
ALBERTS, DS ;
GRAHAM, V ;
JONES, SE ;
SURWIT, EA ;
MOON, TE .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471
[8]  
ANDREWS PL, 1992, EJC SUPPL, V28, P2
[9]  
[Anonymous], 1995, Ann Oncol, V6, P805
[10]  
[Anonymous], 2011, EMEND APR CAPS